Which is the best aromatase inhibitor for postmenopausal breast cancer?

[1] Michaud L.B.(1999)Risks and benefits of aromatase inhibitors in postmenopausal breast cancer Drug Saf 21 297-309

[2] Buzdar A.U.(1982)Aminoglutethimide as treatment of postmenopausal women with advanced breast carcinoma Ann Intern Med 96 94-101

[3] Santen R.J.(1994)Second generation aromatase inhibitor — 4-hydroxyandrostenedione Breast Cancer Res Treat 30 81-7

[4] Worgul T.J.(1992)Exemestane (FCE24304), a new steroidal aromatase inhibitor J Steroid Biochem Mol Biol 43 137-43

[5] Lipton A.(1997)Pharmacokinetic interaction between letrozole and tamoxifen in postmenopausal patients with advanced breast cancer [abstract] Breast 6 245-42

[6] Dowsett M.(1996)Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors J Natl Cancer Inst 88 1529-undefined

[7] Coombes R.C.(1997)Efficacy of anastrozole (Arimidex®) in a consecutive series of advanced breast cancer patients: M.D. Anderson Cancer Center (MDACC) experience [abstract no. 641] Proc Am Soc Clin Oncol 16 183a-undefined

[8] Di Salle E.(undefined)undefined undefined undefined undefined-undefined

[9] Ornati G.(undefined)undefined undefined undefined undefined-undefined

[10] Giudici D.(undefined)undefined undefined undefined undefined-undefined

[1] Michaud L.B.(1999)Risks and benefits of aromatase inhibitors in postmenopausal breast cancer Drug Saf 21 297-309

[2] Buzdar A.U.(1982)Aminoglutethimide as treatment of postmenopausal women with advanced breast carcinoma Ann Intern Med 96 94-101

[3] Santen R.J.(1994)Second generation aromatase inhibitor — 4-hydroxyandrostenedione Breast Cancer Res Treat 30 81-7

[4] Worgul T.J.(1992)Exemestane (FCE24304), a new steroidal aromatase inhibitor J Steroid Biochem Mol Biol 43 137-43

[5] Lipton A.(1997)Pharmacokinetic interaction between letrozole and tamoxifen in postmenopausal patients with advanced breast cancer [abstract] Breast 6 245-42

[6] Dowsett M.(1996)Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors J Natl Cancer Inst 88 1529-undefined

[7] Coombes R.C.(1997)Efficacy of anastrozole (Arimidex®) in a consecutive series of advanced breast cancer patients: M.D. Anderson Cancer Center (MDACC) experience [abstract no. 641] Proc Am Soc Clin Oncol 16 183a-undefined

[8] Di Salle E.(undefined)undefined undefined undefined undefined-undefined

[9] Ornati G.(undefined)undefined undefined undefined undefined-undefined

[10] Giudici D.(undefined)undefined undefined undefined undefined-undefined